Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M
Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
J Am Coll Cardiol. 1993 Jun;21(7):1557-63. doi: 10.1016/0735-1097(93)90368-b.
Serial angiographic follow-up study was designed to evaluate the temporal mode of lumen diameter changes after Palmaz-Schatz stent implantation, and the results were compared with those from a cohort of patients undergoing balloon angioplasty.
Restenosis remains a major limitation of balloon angioplasty. The Palmaz-Schatz balloon expandable coronary stent is now under clinical investigation to evaluate its efficacy in preventing restenosis.
Serial angiographic follow-up study was performed the day after stent implantation and at 1, 3 and 6 months after the procedure. The stent group consisted of 96 patients who had 97 lesions with a single stent. A cohort of 179 patients with 192 lesions were selected as the balloon group by the criteria of final balloon size > or = 3 mm and lesion length < 20 mm.
A significantly larger lumen diameter was obtained immediately after stent implantation (2.9 +/- 0.4 mm [mean +/- SD] in the stent group vs. 2.1 +/- 0.5 mm in the balloon group, p < 0.001). At 3 to 6 months of follow-up, a significantly larger lumen diameter was maintained in the stent group (2.2 +/- 0.6 vs. 1.5 +/- 0.7 mm, p < 0.001). The late restenosis rate according to a binary definition was significantly lower in the stent group (13% vs. 39%, p < 0.001). Stenosis exacerbation, frequently observed within 24 h after balloon angioplasty, was not found after stenting. Between the next day and 1 month, regression was dominant in the balloon group, whereas progression of stenosis was observed in the stent group. The greatest tendency to restenosis was observed in both groups between 1 and 3 months after the procedure. Between 3 and 6 months, significantly greater diameter loss was found in the stent group.
The Palmaz-Schatz stent was effective in reducing the restenosis rate in this highly selected cohort of patients. Reduction in restenosis rate was dependent on a larger lumen obtained immediately. Late loss of diameter was significantly greater after stenting. The restenosis rate after stenting should be evaluated by follow-up angiography at 6 months rather than at 3 months, which is adequate after conventional balloon angioplasty.
设计一项连续血管造影随访研究,以评估Palmaz-Schatz支架植入术后管腔直径变化的时间模式,并将结果与接受球囊血管成形术的一组患者的结果进行比较。
再狭窄仍然是球囊血管成形术的主要局限性。Palmaz-Schatz球囊扩张冠状动脉支架目前正在进行临床研究,以评估其预防再狭窄的疗效。
在支架植入术后第1天以及术后1、3和6个月进行连续血管造影随访研究。支架组由96例患者组成,这些患者有97处病变且植入了单个支架。根据最终球囊尺寸≥3mm且病变长度<20mm的标准,选择179例有192处病变的患者作为球囊组。
支架植入后立即获得了明显更大的管腔直径(支架组为2.9±0.4mm[平均值±标准差],球囊组为2.1±0.5mm,p<0.001)。在随访的3至6个月时,支架组维持了明显更大的管腔直径(2.2±0.6对1.5±0.7mm,p<0.001)。根据二元定义,支架组的晚期再狭窄率明显更低(13%对39%,p<0.001)。在球囊血管成形术后24小时内经常观察到的狭窄加重在支架植入后未发现。在术后第2天至1个月之间,球囊组以管腔直径缩小为主,而支架组观察到狭窄进展。在术后1至3个月之间,两组中观察到的再狭窄倾向最大。在3至6个月之间,支架组的直径损失明显更大。
在这一经过高度选择的患者队列中,Palmaz-Schatz支架在降低再狭窄率方面有效。再狭窄率的降低取决于立即获得的更大管腔。支架植入后晚期直径损失明显更大。支架植入后的再狭窄率应在6个月时通过随访血管造影进行评估,而不是在3个月时,3个月对传统球囊血管成形术来说是足够的。